Pulmonary Hypertension Drugs Market will Grow Owing to Telehealth Adoption
Pulmonary hypertension (PH) drugs encompass a range of therapies—including endothelin receptor antagonists, phosphodiesterase-5 inhibitors and prostacyclin analogues—designed to lower pulmonary arterial pressure and improve right ventricular function. These treatments offer significant advantages such as enhanced exercise capacity, symptom reli